| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 17.00 | 0.33 (+1.98%) | 16.37 - 30.59 | 777.9 thousand (Below Avg) |
Market data as of 4:00PM 05/23/13. Quotes are delayed by at least 15 min.
| Open | 16.58 |
|---|---|
| Previous Close | 16.67 |
| Day's Range | 16.58 - 17.00 |
| Market Cap | 927.2M |
| Avg Volume (10 Day) | 1.4M |
| Price/Earnings (Trailing 12 Mo.) | 185.2x |
| Earnings Per Share (Trailing 12 Mo.) | 0.09 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Fail |
| Increased shareholder value? | Fail |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Neutral |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Neutral |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Neutral |
| Borrows within reasonable limits? | Fail |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013
PR Newswire - Thursday 05/23/2013 4:30 AM ET
Volcano Corporation Announces Presentations At Upcoming Investor Conferences
PR Newswire - Wednesday 05/22/2013 8:00 AM ET
Verrata™ Pressure Guide Wire and iFR® (Instant Wave-Free Ratio™) Software Modality will be on display at EuroPCR 2013[1]
PR Newswire - Tuesday 05/21/2013 4:40 AM ET
Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013
PR Newswire - Monday 05/20/2013 8:38 PM ET
Volcano Announces First Quarter Results
PR Newswire - Thursday 05/02/2013 4:05 PM ET
Volcano Corporation Schedules First Quarter Conference Call, Webcast
PR Newswire - Monday 04/22/2013 8:00 AM ET
| VOLC | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 9.02% | |
| Net Income Growth (1yr) | -87.66% | |
| Total Debt/Equity | 0.94 | |
| LT Debt/Equity | 0.94 | |
| Earnings Yield | 0.54% | |
| Price/Sales | 2.36 |
| Company | Last | Change |
|---|---|---|
| Conmed Corp | 33.54 | +0.78% |
| ArthroCare Corp | 33.64 | +0.93% |
| Abiomed Inc | 21.72 | -0.50% |
| Nxstage Medical Inc | 13.60 | -1.02% |
| NuVasive Inc | 22.20 | -1.64% |
Data is delayed by at least 15 min.